Emerging viral diseases and infectious disease risks
| Autor: | M. L. Tapper |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2006 |
| Předmět: |
Disease reservoir
medicine.medical_specialty human immunodeficiency virus business.industry Public health Outbreak haemophilia pathogens Hematology General Medicine severe acute respiratory syndrome medicine.disease_cause Virology Influenza A virus subtype H5N1 Infectious disease (medical specialty) Global health Medicine Blood-Borne Pathogens avian influenza business Intensive care medicine Review Articles West Nile virus Genetics (clinical) Coronavirus |
| Zdroj: | Haemophilia |
| ISSN: | 1365-2516 1351-8216 |
| Popis: | Summary. New pathogens and antimicrobial‐resistant forms of older pathogens continue to emerge, some with the potential for rapid, global spread and high morbidity and mortality. Pathogens can emerge either through introduction into a new population or when the interaction with the vector changes; emergence is also influenced by microbiological adaptation and change, global travel patterns, domestic and wild animal contact and other variants in human ecology and behaviour. Quick, decisive action to detect and control novel pathogens, and thereby contain outbreaks and prevent further transmission, is frequently hampered by incomplete or inadequate data about a new or re‐emerging pathogen. Three examples of pathogens that are current causes for human health concern are avian influenza, West Nile virus (WNV) and the severe acute respiratory syndrome (SARS) coronavirus. Pathogens directly or indirectly transmitted by aerosolized droplets, such as avian influenza and SARS, pose considerable containment challenges. Rapid screening tests for other newly described pathogens such as WNV require time for development and may be |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|